FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39255411000001108: Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jan 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1721121000001114 Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1721141000001116 Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Is a Atezolizumab 840mg/14ml solution for infusion vials true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Is a Tecentriq true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient Atezolizumab true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has AMP True Tecentriq 840mg/14ml concentrate for solution for infusion vials (Originalis B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start